IMUNOHISTOCHEMISTRY NAPSIN-A Test
Cost: AED 500.0
Test Name: IMUNOHISTOCHEMISTRY NAPSIN-A Test
Components: NAPSIN-A Test
Price: 500.0 AED
Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery: Sample Daily by 6 pm; Report Block: 5 days, Tissue Biopsy: 5 days, Tissue large complex: 7 days
Method: Immunohistochemistry
Test type: Cancer
Doctor: Oncologist, Pathologist
Test Department:
Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details
The NAPSIN-A test is an immunohistochemistry (IHC) test used in pathology to detect the presence of Napsin-A protein in tissue samples. Napsin-A is an enzyme that is primarily expressed in the lung, specifically in type II pneumocytes and alveolar macrophages. It is commonly used as a marker for lung adenocarcinoma, as it is highly expressed in this type of cancer.
The NAPSIN-A test involves staining tissue sections with specific antibodies that bind to Napsin-A protein. The antibodies are usually labeled with a colored or fluorescent marker, allowing for visualization under a microscope. If Napsin-A is present in the tissue sample, it will be detected as a positive staining signal.
The NAPSIN-A test is often performed in conjunction with other IHC markers, such as TTF-1 (thyroid transcription factor-1), to aid in the diagnosis and classification of lung adenocarcinoma. The results of the NAPSIN-A test can help pathologists determine the origin of a tumor and differentiate lung adenocarcinoma from other types of lung cancer or metastatic tumors.
Overall, the NAPSIN-A test is a valuable tool in the field of pathology for the identification and characterization of lung adenocarcinoma, helping guide treatment decisions and prognosis assessment for patients with this type of cancer.
| Test Name | IMUNOHISTOCHEMISTRY NAPSIN-A Test |
|---|---|
| Components | |
| Price | 500.0 AED |
| Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Report Delivery | Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist, Pathologist |
| Test Department: | |
| Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Test Details |
The NAPSIN-A test is an immunohistochemistry (IHC) test used in pathology to detect the presence of Napsin-A protein in tissue samples. Napsin-A is an enzyme that is primarily expressed in the lung, specifically in type II pneumocytes and alveolar macrophages. It is commonly used as a marker for lung adenocarcinoma, as it is highly expressed in this type of cancer. The NAPSIN-A test involves staining tissue sections with specific antibodies that bind to Napsin-A protein. The antibodies are usually labeled with a colored or fluorescent marker, allowing for visualization under a microscope. If Napsin-A is present in the tissue sample, it will be detected as a positive staining signal. The NAPSIN-A test is often performed in conjunction with other IHC markers, such as TTF-1 (thyroid transcription factor-1), to aid in the diagnosis and classification of lung adenocarcinoma. The results of the NAPSIN-A test can help pathologists determine the origin of a tumor and differentiate lung adenocarcinoma from other types of lung cancer or metastatic tumors. Overall, the NAPSIN-A test is a valuable tool in the field of pathology for the identification and characterization of lung adenocarcinoma, helping guide treatment decisions and prognosis assessment for patients with this type of cancer. |
